From Ozempic to BPC-157, graded on the evidence
48 peptides, approved or not, with their risks, what users report and the law where you live. Nothing here is for sale.
FilterFat & metabolism
Body part
Whole-body effect
Fat & metabolism 18 peptides
Weight, appetite and blood sugar.
Sort by
SemaglutideWeight loss in obesity +1 moreProvenPrescriptionVery highWikipedia attention: Very high. Falling. Data through Sep 2026TirzepatideWeight loss in obesity +1 moreProvenPrescriptionVery highWikipedia attention: Very high. Steady. Data through Sep 2026LiraglutideWeight loss in obesity +1 moreProvenPrescriptionModerateWikipedia attention: Moderate. Steady. Data through Sep 2026OrforglipronNot a peptide, newWeight loss in obesity +1 moreProvenPrescriptionModerateWikipedia attention: Moderate. Falling. Data through Sep 2026TesamorelinBelly fat in HIV-related lipodystrophyProvenPrescriptionModerateWikipedia attention: Moderate. Steady. Data through Sep 2026SetmelanotideObesity from rare genetic causes +1 moreProvenPrescriptionVery lowWikipedia attention: Very low. Steady. Data through Sep 2026RetatrutideUpcomingWeight loss in obesity +1 moreSupportedTrials onlyVery highWikipedia attention: Very high. Falling. Data through Sep 2026CagriSemaUpcomingWeight loss in obesity +1 moreSupportedUnder reviewModerateWikipedia attention: Moderate. Steady. Data through Sep 2026AmycretinUpcomingWeight lossSupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026EloralintideUpcomingWeight loss in obesitySupportedTrials onlyVery lowWikipedia attention: Very low. Insufficient history. Data through Sep 2026MariTideAntibody conjugate, upcomingWeight loss in obesitySupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026MazdutideUpcomingWeight loss and type 2 diabetesSupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026PetrelintideUpcomingWeight loss in obesitySupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026SurvodutideUpcomingWeight loss in obesitySupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026GHRP-2 and GHRP-6Appetite stimulationEarlyNot approvedVery lowWikipedia attention: Very low. Falling. Data through Sep 2026Melanotan IIAppetite suppressionLab onlyRules in fluxModerateWikipedia attention: Moderate. Falling. Data through Sep 2026MOTS-cFat loss and blood sugarLab onlyRules in fluxLowWikipedia attention: Low. Falling. Data through Sep 2026AOD-9604Fat lossFailedNot approvedVery lowWikipedia attention: Very low. Falling. Data through Sep 2026